m+Medelevator.RU
← Поиск публикаций
Nature · 2025

Parity and lactation induce T-cell-mediated breast cancer protection.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Virassamy Balaji, Caramia Franco, Savas Peter, Harris Michael A, Pan Jia-Wern, Wang Jianan, Brown Emmaline, O'Malley Megan M R, van Geelen Courtney T, Hun Michael, Burn Thomas N, Sant Sneha, Ballan Jamieson D, Kay Jasmine, Lara Gonzalez Luis E, Clarke Kylie, Aw Yeang Han Xian, Idrizi Rejhan, Jana Metta, Challice Damon J, Salgado Roberto, Thorne Heather, kConFab consortium, Poliness Cathie, Nightingale Sophie, Teo Soo-Hwang, Speed Terence P, Visvader Jane, Neeson Paul J, Darcy Phillip K, Mackay Laura K, Loi Sherene

Аннотация

Parity and breastfeeding reduce the risk of breast cancer, particularly triple-negative breast cancer (TNBC)1,2, yet the immunological mechanisms underlying this protection remain unclear. Here we show that parity is associated with increased numbers of CD8+ T cells, including cells with a tissue-resident-memory-like phenotype within human normal breast tissue. In mouse models, pregnancy followed by lactation and involution drove the accumulation of CD8+ T cells in the mammary gland, coinciding with reduced tumour growth and increased intratumoural immune cell infiltration, effects that were abrogated by CD8+ T cell depletion. Importantly, this CD8+ T-cell-dependent tumour control was observed only after a complete cycle of lactation and involution. Consistent with this, primary triple-negative breast cancers from parous women exhibited greater T cell infiltration and improved clinical outcomes. Together, these findings, spanning preclinical models and over 1,000 patient samples, provide insights into how reproductive history shapes breast immunity, positioning CD8+ T cells as key mediators of parity-associated protection and informing strategies for both the prevention and the treatment of breast cancer.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты